Post Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him
Post The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
Post For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size
Post Parker Institute Researchers Featured at Fourth International Immunotherapy Conference 2018 in New York #CICON18
Post Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer